Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.59 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.53 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13779410 | 0.87 | HPGD (0.53) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL21372579 | 0.85 | TDP1 (0.56) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL28702056 | 0.85 | TDP1 (0.56) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL529123 | 0.85 | KDM4E (0.51) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL2575314 | 0.84 | EPHX1 (0.55) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL2575317 | 0.84 | TDP1 (0.59) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL23932603 | 0.83 | MEN1 (0.52) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL6421722 | 0.83 | MTNR1A (0.58) | MEN1KMT2APARP10SLC1A3SLC1A2 | |
| SCHEMBL29501710 | 0.82 | SMN1; SMN2 (0.48) | PARP10PARP15ALDH1A1CYP1A2 | |
| SCHEMBL5933380 | 0.82 | EPHX1 (0.54) | MEN1KMT2APARP10SLC1A3SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056270-A | Pesticide suspension concentrate and fertilizer composition thereof | 诺力昂化学品国际有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-101641332-B | Aminated hydroxyquinoline derivatives for the treatment of cancer | BIOPHARMED | 2014-03-12 | — | — | CN | claimed |
| CN-101641332-A | Aminated hydroxyquinoline derivatives for the treatment of cancer | BIOPHARMED SARL FR | 2010-02-03 | — | — | CN | claimed |
| US-20050026994-A1 | Use of 2, 4diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors | FRANCE DENNIS (US) | 2005-02-03 | — | — | US | claimed |
| EP-1435352-A2 | 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | Wyeth Holdings Corporation (US) | 2004-07-07 | — | — | EP | claimed |
| EP-0618190-B1 | 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | WYETH CORP (US) | 2004-05-19 | — | — | EP | claimed |
| EP-1289940-A2 | EXCITATORY AMINO ACID RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2003-03-12 | — | — | EP | claimed |
| WO-2001092213-A2 | EXCITATORY AMINO ACID RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2001-12-06 | — | — | WO | claimed |
| US-5371076-A | ANTIBIOTICS | AMERICAN CYANAMID COMPANY (US) | 1994-12-06 | — | — | US | claimed |
| EP-0618190-A1 | 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines | AMERICAN CYANAMID COMPANY (US) | 1994-10-05 | — | — | EP | claimed |
| JP-58113109-A | — | — | None | — | — | JP | disclosed |
| JP-63088106-A | — | — | None | — | — | JP | disclosed |
| CN-122056270-A | Pesticide suspension concentrate and fertilizer composition thereof | 诺力昂化学品国际有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-117890350-A | Preparation of gold-silver alloy-metal organic frame paper-based Raman sensor and application of gold-silver alloy-metal organic frame paper-based Raman sensor in carbaryl detection | 济南大学 | 2024-04-16 | — | — | CN | disclosed |
| CN-111808011-B | High penetration composition and its application | 泰飞尔生物医药(苏州)有限公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-0272583-A2 | 5-Substituted amino-4-hydroxy-pentenoic acid derivatives and their use | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-06-29 | — | — | EP | disclosed |
| EP-0264106-A2 | 5-Substituted amino-4-hydroxy-pentanoic acid derivatives and their use | Banyu Pharmaceutical Co., Ltd. (JP) | 1988-04-20 | — | — | EP | disclosed |
| JP-S6388106-A | CONTROLLING COMPOSITION AGAINST RESISTANT NEPHOTETTIX CINCTICEPS UHLERA | NIPPON NOHYAKU CO LTD | 1988-04-19 | — | — | JP | disclosed |
| JP-S58113109-A | COMPOSITE INSECTICIDE | NIPPON TOKUSHU NOYAKU SEIZO KK | 1983-07-05 | — | — | JP | disclosed |
| JP-S06388106-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026994-A1 | Use of 2, 4diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors | PSMB3, PSMB2, PSMB1 | MEN1 3718/4885KMT2A 588/4885PARP10 1963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.